90 related articles for article (PubMed ID: 20005677)
21. [Cloning and expression of a synthetic gene encoding magainin-melittin hybrid peptide in Escherichia coli and studies on its antibacterial activity].
Huang Y; Liu FP; Zhou TH; Zhu JM
Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):207-10. PubMed ID: 11411233
[TBL] [Abstract][Full Text] [Related]
22. Expression of a cytotoxic cationic antibacterial peptide in Escherichia coli using two fusion partners.
Chen YQ; Zhang SQ; Li BC; Qiu W; Jiao B; Zhang J; Diao ZY
Protein Expr Purif; 2008 Feb; 57(2):303-11. PubMed ID: 17977015
[TBL] [Abstract][Full Text] [Related]
23. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.
Hale JD; Hancock RE
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):951-9. PubMed ID: 18039080
[TBL] [Abstract][Full Text] [Related]
24. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
25. Expression of recombinant hybrid peptide cecropinA(1-8)-magainin2(1-12) in Pichia pastoris: purification and characterization.
Jin F; Xu X; Wang L; Zhang W; Gu D
Protein Expr Purif; 2006 Dec; 50(2):147-56. PubMed ID: 16931049
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.
Benincasa M; Scocchi M; Podda E; Skerlavaj B; Dolzani L; Gennaro R
Peptides; 2004 Dec; 25(12):2055-61. PubMed ID: 15572192
[TBL] [Abstract][Full Text] [Related]
29. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm.
Wei GX; Campagna AN; Bobek LA
J Antimicrob Chemother; 2006 Jun; 57(6):1100-9. PubMed ID: 16595638
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of antibiotics and antimicrobial peptides against the plant pathogenic bacterium Xylella fastidiosa.
Kuzina LV; Miller TA; Cooksey DA
Lett Appl Microbiol; 2006 May; 42(5):514-20. PubMed ID: 16620212
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial drug resistance in Taiwan.
Huang YT; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S174-8. PubMed ID: 19013350
[TBL] [Abstract][Full Text] [Related]
32. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
Bragonzi A
Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
[TBL] [Abstract][Full Text] [Related]
33. Investigating specific bacterial resistance to AMPs by using a magainin I-resistant Escherichia coli model.
de Almeida KC; Lima TB; Motta DO; Silva ON; Magalhães BS; Dias SC; Franco OL
J Antibiot (Tokyo); 2014 Oct; 67(10):681-7. PubMed ID: 24802209
[TBL] [Abstract][Full Text] [Related]
34. Investigating the mode of action of proline-rich antimicrobial peptides using a genetic approach: a tool to identify new bacterial targets amenable to the design of novel antibiotics.
Scocchi M; Mattiuzzo M; Benincasa M; Antcheva N; Tossi A; Gennaro R
Methods Mol Biol; 2008; 494():161-76. PubMed ID: 18726573
[TBL] [Abstract][Full Text] [Related]
35. Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner.
Li JF; Zhang J; Song R; Zhang JX; Shen Y; Zhang SQ
Appl Microbiol Biotechnol; 2009 Aug; 84(2):383-8. PubMed ID: 19582446
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
[TBL] [Abstract][Full Text] [Related]
37. [Antibiotic sensitivity of microbial strains isolated from the hospital environment].
Debeleac L; Voicescu V; Dumitrescu MR; Covacu A; Slavov N; Georgescu M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(3):225-34. PubMed ID: 3438652
[No Abstract] [Full Text] [Related]
38. In vitro activities of antimicrobials against six important species of gram-negative bacteria isolated from raw milk samples in Korea.
Nam HM; Lim SK; Kim JM; Joo YS; Jang KC; Jung SC
Foodborne Pathog Dis; 2010 Feb; 7(2):221-4. PubMed ID: 19895257
[TBL] [Abstract][Full Text] [Related]
39. Are cationic antimicrobial peptides also 'double-edged swords'?
Ginsburg I; Koren E
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):453-62. PubMed ID: 18662113
[TBL] [Abstract][Full Text] [Related]
40. Brevinin-1BYa: a naturally occurring peptide from frog skin with broad-spectrum antibacterial and antifungal properties.
Pál T; Abraham B; Sonnevend A; Jumaa P; Conlon JM
Int J Antimicrob Agents; 2006 Jun; 27(6):525-9. PubMed ID: 16713189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
